214 related articles for article (PubMed ID: 34615934)
1. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
Lucchetta M; Pellegrini M
Sci Rep; 2021 Oct; 11(1):19839. PubMed ID: 34615934
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
Le BL; Andreoletti G; Oskotsky T; Vallejo-Gracia A; Rosales R; Yu K; Kosti I; Leon KE; Bunis DG; Li C; Kumar GR; White KM; García-Sastre A; Ott M; Sirota M
Sci Rep; 2021 Jun; 11(1):12310. PubMed ID: 34112877
[TBL] [Abstract][Full Text] [Related]
3. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
O'Donovan SM; Imami A; Eby H; Henkel ND; Creeden JF; Asah S; Zhang X; Wu X; Alnafisah R; Taylor RT; Reigle J; Thorman A; Shamsaei B; Meller J; McCullumsmith RE
Sci Rep; 2021 Feb; 11(1):4495. PubMed ID: 33627767
[TBL] [Abstract][Full Text] [Related]
5. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.
Zhu H; Chen CZ; Sakamuru S; Zhao J; Ngan DK; Simeonov A; Hall MD; Xia M; Zheng W; Huang R
Sci Rep; 2021 Mar; 11(1):6725. PubMed ID: 33762619
[TBL] [Abstract][Full Text] [Related]
6. PROMISCUOUS 2.0: a resource for drug-repositioning.
Gallo K; Goede A; Eckert A; Moahamed B; Preissner R; Gohlke BO
Nucleic Acids Res; 2021 Jan; 49(D1):D1373-D1380. PubMed ID: 33196798
[TBL] [Abstract][Full Text] [Related]
7. LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network.
Zhou D; Peng S; Wei DQ; Zhong W; Dou Y; Xie X
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1290-1298. PubMed ID: 34081583
[TBL] [Abstract][Full Text] [Related]
8. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
[TBL] [Abstract][Full Text] [Related]
9. Network analytics for drug repurposing in COVID-19.
Siminea N; Popescu V; Sanchez Martin JA; Florea D; Gavril G; Gheorghe AM; Iţcuş C; Kanhaiya K; Pacioglu O; Popa LL; Trandafir R; Tusa MI; Sidoroff M; Păun M; Czeizler E; Păun A; Petre I
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864885
[TBL] [Abstract][Full Text] [Related]
10. Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.
Zambrana C; Xenos A; Böttcher R; Malod-Dognin N; Pržulj N
Sci Rep; 2021 Sep; 11(1):18985. PubMed ID: 34556735
[TBL] [Abstract][Full Text] [Related]
11. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
Gates LE; Hamed AA
J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
[TBL] [Abstract][Full Text] [Related]
12. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
13. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
Belyaeva A; Cammarata L; Radhakrishnan A; Squires C; Yang KD; Shivashankar GV; Uhler C
Nat Commun; 2021 Feb; 12(1):1024. PubMed ID: 33589624
[TBL] [Abstract][Full Text] [Related]
14. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
Bonnet R; Mariault L; Peyron JF
PLoS One; 2022; 17(1):e0262751. PubMed ID: 35085325
[TBL] [Abstract][Full Text] [Related]
15. A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.
Mongia A; Saha SK; Chouzenoux E; Majumdar A
Sci Rep; 2021 Apr; 11(1):9047. PubMed ID: 33907209
[TBL] [Abstract][Full Text] [Related]
16. An
Li Z; Yao Y; Cheng X; Li W; Fei T
STAR Protoc; 2021 Sep; 2(3):100653. PubMed ID: 34286288
[TBL] [Abstract][Full Text] [Related]
17. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
Rakshit H; Chatterjee P; Roy D
Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.
Ojha PK; Kar S; Krishna JG; Roy K; Leszczynski J
Mol Divers; 2021 Feb; 25(1):625-659. PubMed ID: 32880078
[TBL] [Abstract][Full Text] [Related]
19. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
20. Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.
Tan S; Chen W; Xiang H; Kong G; Zou L; Wei L
Genes Genomics; 2021 Jan; 43(1):55-67. PubMed ID: 33428154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
